<SEC-DOCUMENT>0001127602-22-014225-index.html : 20220512
<SEC-HEADER>0001127602-22-014225.hdr.sgml : 20220512
<ACCEPTANCE-DATETIME>20220512135956
ACCESSION NUMBER:		0001127602-22-014225
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220510
FILED AS OF DATE:		20220512
DATE AS OF CHANGE:		20220512

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mulligan Richard
		CENTRAL INDEX KEY:			0001376247

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14956
		FILM NUMBER:		22917116

	MAIL ADDRESS:	
		STREET 1:		C/O ICAHN CAPITAL LP
		STREET 2:		767 FIFTH AVENUE, SUITE 4700
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10153

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bausch Health Companies Inc.
		CENTRAL INDEX KEY:			0000885590
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8
		BUSINESS PHONE:		514-744-6792

	MAIL ADDRESS:	
		STREET 1:		2150 ST. ELZEAR BLVD. WEST
		STREET 2:		LAVAL
		CITY:			QUEBEC
		STATE:			A8
		ZIP:			H7L 4A8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Valeant Pharmaceuticals International, Inc.
		DATE OF NAME CHANGE:	20100928

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL Corp
		DATE OF NAME CHANGE:	20100416

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOVAIL CORP INTERNATIONAL
		DATE OF NAME CHANGE:	19960522
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form3.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: form3.html

Document 1 - RAW XML: form3.xml

</DOCUMENT>
</SEC-DOCUMENT>